Mr. Speaker, as I mentioned earlier, just yesterday we received the report of the Canadian biotechnology advisory committee and we will be examining its analysis and recommendations very closely in the period ahead.
Taken together with cases which are before the country's highest court, these issues have to be considered by the government and by the House. Therefore, I assure the member that we will be looking very closely at these recommendations to see what is in the public interest.